Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Vaccine Conjugates Companies

Vaccine conjugates companies specialize in the development and production of conjugate vaccines. Conjugate vaccines are created by combining a bacterial or viral antigen with a carrier protein, enhancing the immune system's response, particularly in the case of certain bacteria that have polysaccharide capsules. These vaccines are crucial in preventing infections caused by bacteria like Haemophilus influenzae type b (Hib), Streptococcus pneumoniae, and Neisseria meningitidis.

Vaccine Conjugates Market

Latest Vaccine Conjugates Companies Updates

Pfizer Inc. (US): Received FDA approval for its Prevnar 20® pneumococcal conjugate vaccine for adults in October 2023, expanding its market reach and potential revenue stream.

Merck & Co., Inc. (US): Partnered with PATH (US) in September 2023 to develop and introduce a new MenB vaccine conjugate for low- and middle-income countries, addressing global health disparities.

GlaxoSmithKline plc (UK): Highlighted its ongoing development of a malaria vaccine conjugate in its recent investor presentation, showcasing its commitment to innovative vaccine solutions.

Bharat Biotech International Limited (India): Announced successful Phase 3 clinical trials for its Typhoid Conjugate Vaccine in July 2023, paving the way for potential market entry and wider access to this important vaccine.

Novavax, Inc. (US): Presented promising preclinical data for its respiratory syncytial virus (RSV) F protein conjugate vaccine candidate in September 2023, adding to the pipeline of potential new conjugate vaccines.

List of Vaccine Conjugates Key companies in the market:

Bharat Biotech (India)

GlaxoSmithKline Plc (UK)

Serum Institute of India

Sanofi Pasteur (France)

Merck and Company (US)

CSL Limited (Australia)

Pfizer Inc. (US)

Novartis AG (Switzerland)

Neuron Biotech (the US)

Biological E (India)

Vaccine Conjugates Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.